News search

    E.g., 08/06/2025
    E.g., 08/06/2025
    Grupo de la Dra. Priori
    Research
    21 Jul 2021
    A CNIC project receives funding from the ”la Caixa” Foundation to investigate a type of fatal tachycardia

    The research team led by project leader Dr Silvia Priori is confident that the discovery of new therapies will reduce the mortality linked to this disease and could also reduce arrhythmias in heart failure patients

    Imagen
    About the CNIC
    29 Jun 2021
    RESILIENCE, a project to reduce the prevalence of heart failure in cancer survivors

     Over one million European cancer patients suffer from side effects to chemotherapy
    Scheme of a cMyBP-C region in which mutations cause amino-acid changes that alter the mechanical properties of the protein. The positions of the affected amino acids are shown in red.
    Research
    7 Jun 2021
    ACS Nano: CNIC scientists describe a possible disease-causing mechanism in hypertrophic cardiomyopathy

    A team led by Dr. Jorge Alegre-Cebollada has shown, for the first time, an association between hypertrophic cardiomyopathy and mechanical alterations to a component of the contractile machinery of the heart
    Dr. Miguel Torres
    About the CNIC
    10 May 2021
    Dr. Miguel Torres appointed Associate Editor of Science Advances

    Dr. Torres is a member of the European Molecular Biology Organization (EMBO). Dr. Miguel Torres’s scientific research focuses on the regulation of embryonic development and the formation and regeneration of organs.

    3D images obtained in anatomical, functional, and tissue characterization studies performed with the ultrafast cardiac magnetic resonance protocol
    Research
    22 Apr 2021
    JACC: CNIC and Philips develop ultrafast cardiac magnetic resonance technology that analyzes the heart in less than 1 minute

    Ultrafast cardiac magnetic resonance allows precise assessment of heart anatomy and function while reducing healthcare costs and increasing patient comfort
    Mª Ángeles Zuriaga, Mirian Díez, Fátima Sánchez-Cabo, Ana Dopazo, José Javier Fuster, Ana Quintas y Jorge de la Barrera.
    Research
    5 Apr 2021
    JACC: CNIC scientists identify mutations acquired by blood cells that accelerate heart failure progression

    The study, carried out at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) and the Hospital Universitario Virgen de Arrixaca in Murcia, establishes clonal hematopoiesis as a new cardiovascular risk factor and an important link between aging and cardiovascular disease
    Mapa de T1 obtenido con SACORA y valores promedios
    About the CNIC
    22 Mar 2021
    CNIC and Philips develop a technique that enables assessment of heart anatomy by MRI in only 15 seconds

    The development of this 3D T1 mapping technique, called "SACORA", comes as part of the ongoing collaboration between CNIC and Philips
    Valentín Fuster
    About the CNIC
    25 Feb 2021
    The Association of Cardiovascular Imaging of the Spanish Society of Cardiology (SEC) awards its Gold Medal to Dr Valentín Fuster

    Dr Valentín Fuster, Director of the Spanish National Centre for Cardiovascular Research (CNIC) is to receive the Gold Medal of the Association of Cardiovascular Imaging of the Spanish Society of Cardiology (SEC) for his original and innovative scientific activity in cardiovascular imaging to reach new frontiers in cardiovascular health of the heart and brain.
    Marta Amorós Pérez, Virginia Zorita, Nuria Matesanz, Marian Zuriaga y José Javier Fuster.
    About the CNIC
    23 Dec 2020
    CNIC to coordinate a European project investigating how cancer therapies promote atherosclerosis and cardiovascular disease

    The project will investigate the role of clonal hematopoiesis—the formation of mutated hematopoietic stem-cell clones promoted by anti-cancer therapies—in the development of atherosclerosis and associated cardiovascular disease
    Irene Fernández-Nueda, Carlos Cerón y Marta Cortés-Canteli
    About the CNIC
    15 Dec 2020
    CNIC scientists coordinate a European project to develop a biomarker for the early identification of the vascular component in Alzheimer disease

    The BioClotAD project, coordinated by CNIC scientist Dr Marta Cortés Canteli, has been selected by the EU Joint Programme – Neurodegenerative Disease Research (JPND)